TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

SIMPLE SUMMARY: There is conflicting evidence on the impact of TP53 co-mutations on survival in patients with EGFR-mutated advanced non-small cell lung cancer (aNSCLC). This observational study used data from a de-identified database to assess the role of TP53 co-mutation on survival in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Xiuning, Molife, Cliff, Leusch, Mark S., Rizzo, Maria Teresa, Peterson, Patrick M., Caria, Nicola, Chen, Yongmei, Gugel, Elena Gonzalez, Visseren-Grul, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776757/
https://www.ncbi.nlm.nih.gov/pubmed/36551611
http://dx.doi.org/10.3390/cancers14246127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776757/
https://www.ncbi.nlm.nih.gov/pubmed/36551611
http://dx.doi.org/10.3390/cancers14246127

Ejemplares similares